136 related articles for article (PubMed ID: 7081323)
1. Oral contraceptives and prolactinomas: a case-control study.
Maheux R; Jenicek M; Cleroux R; Beauregard H; De Muylder X; Gratton NM; Van Campenhout J
Am J Obstet Gynecol; 1982 May; 143(2):134-8. PubMed ID: 7081323
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive exposure of amenorrheic women with and without prolactinomas.
Jones JR; Kemmann E; Norwood PK
Int J Gynaecol Obstet; 1981 Oct; 19(5):381-7. PubMed ID: 6120108
[TBL] [Abstract][Full Text] [Related]
3. Prolonged amenorrhea and oral contraceptives.
Tolis G; Ruggere D; Popkin DR; Chow J; Boyd ME; De Leon A; Lalonde AB; Asswad A; Hendelman M; Scali V; Koby R; Arronet G; Yufe B; Tweedie FJ; Fournier PR; Naftolin F
Fertil Steril; 1979 Sep; 32(3):265-8. PubMed ID: 385358
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive steroids do not promote the development or growth of prolactinomas.
Hulting AL; Werner S; Hagenfeldt K
Contraception; 1983 Jan; 27(1):69-73. PubMed ID: 6839760
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenoma and oral contraceptives: a case-control study.
Coulam CB; Annegers JF; Abboud CF; Laws ER; Kurland LT
Fertil Steril; 1979 Jan; 31(1):25-8. PubMed ID: 369889
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive history as a risk indicator in patients with pituitary tumors with hyperprolactinemia: a case comparison study of twenty patients.
Teperman L; Futterweit W; Zappulla R; Malis LI
Neurosurgery; 1980 Dec; 7(6):571-3. PubMed ID: 7193811
[TBL] [Abstract][Full Text] [Related]
7. Two-year treatment with oral contraceptives in hyperprolactinemic patients.
Testa G; Vegetti W; Motta T; Alagna F; Bianchedi D; Carlucci C; Bianchi M; Parazzini F; Crosignani PG
Contraception; 1998 Aug; 58(2):69-73. PubMed ID: 9773260
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive steroid effects on nonreproductive organ systems.
Corson SL
J Reprod Med; 1986 Sep; 31(9 Suppl):865-78. PubMed ID: 3772906
[TBL] [Abstract][Full Text] [Related]
9. Contraceptive choices for women with endocrine complications.
Loriaux DL; Wild RA
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 2):2021-6. PubMed ID: 8512047
[TBL] [Abstract][Full Text] [Related]
10. The effect of contraceptive steroids on hypothalamic-pituitary function.
Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
[TBL] [Abstract][Full Text] [Related]
11. Pituitary prolactinoma and estrogen contraceptives.
Vaisrub S
JAMA; 1979 Jul; 242(2):177-8. PubMed ID: 12309457
[TBL] [Abstract][Full Text] [Related]
12. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
Lidegaard O
BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
[TBL] [Abstract][Full Text] [Related]
13. [Sterility and infertility: two concepts].
Rochon M
Cah Que Demogr; 1986 Apr; 15(1):27-56. PubMed ID: 12268268
[TBL] [Abstract][Full Text] [Related]
14. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer among young U.S. women in relation to oral contraceptive use.
White E; Malone KE; Weiss NS; Daling JR
J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
[TBL] [Abstract][Full Text] [Related]
16. [Oral contraceptives and prolactin-producing hypophyseal tumors].
Lamberts SW
Ned Tijdschr Geneeskd; 1980 Jan; 124(4):111-3. PubMed ID: 7374834
[TBL] [Abstract][Full Text] [Related]
17. Primary infertility and oral contraceptive steroid use.
Bagwell MA; Thompson SJ; Addy CL; Coker AL; Baker ER
Fertil Steril; 1995 Jun; 63(6):1161-6. PubMed ID: 7750582
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
19. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
Grimes DA
Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives as related to cancer and benign lesions of the breast.
Fasal E; Paffenbarger RS
J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
